ORIDIGM CORP has a total of 25 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are ESTEVE QUIM S A, FARMOS GROUP LTD and CORSAIR PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | United States | 3 | |
#6 | China | 1 | |
#7 | Japan | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | O'Day Christine L | 14 |
#2 | Burns Mark R | 13 |
#3 | Webb Heather K | 11 |
#4 | Vermeulen Nicolaas M J | 10 |
#5 | Schwartz Dennis E | 9 |
#6 | Bergstrom Donald E | 8 |
#7 | Vermeulin Nicolaas M J | 8 |
#8 | Vermeulin Nicholaas M J | 2 |
#9 | Burns M R | 1 |
#10 | Graminski Gerard F | 1 |
Publication | Filing date | Title |
---|---|---|
CA2433807A1 | Hydrophobic polyamine analogs and methods for their use | |
AU6813901A | Novel polyamine analogues as therapeutic and diagnostic agents | |
CA2318004A1 | Novel polyamine analogues as therapeutic and diagnostic agents | |
EP1159261A2 | Antizyme modulators and their use | |
WO9633703A2 | S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy | |
US6020139A | S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy | |
US5872104A | Combinations and methods for reducing antimicrobial resistance |